» Articles » PMID: 1493807

Functional and Structural Damage in Leishmania Mexicana Exposed to the Cationic Peptide Dermaseptin

Overview
Journal Eur J Cell Biol
Publisher Elsevier
Specialty Cell Biology
Date 1992 Dec 1
PMID 1493807
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of dermaseptin (DS), a 34 amino acid residue cationic peptide isolated from Phyllomedusa sauvagii skin, has been studied on promastigotes of Leishmania mexicana growing in vitro. Within 5 min of incubation in the presence of DS, the flagellated parasites lost their motility. DS inhibited promastigote growth by 50% at a concentration of 3 microM and by 100% at 10 microM. Immunocytochemical, freeze fracture, label fracture and electron microscopic observations have shown that the amphipathic peptide generates perturbations of the lipid bilayer leading to altered permeability of the surface membrane and death of the parasite.

Citing Articles

Antileishmanial Activity and Molecular Modeling Studies of Novel Analogs of Dermaseptins S4 and B2.

Haddad H, Antonio da Franca Rodrigues K, Othman H, Veras L, Rodrigues R, Ouahchi I Curr Pharm Biotechnol. 2024; 26(2):276-288.

PMID: 39257149 DOI: 10.2174/0113892010296038240427050421.


Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease.

Robledo S, Perez-Silanes S, Fernandez-Rubio C, Poveda A, Monzote L, Gonzalez V Pathogens. 2023; 12(7).

PMID: 37513786 PMC: 10383258. DOI: 10.3390/pathogens12070939.


Peptides to Tackle Leishmaniasis: Current Status and Future Directions.

Robles-Loaiza A, Pinos-Tamayo E, Mendes B, Teixeira C, Alves C, Gomes P Int J Mol Sci. 2021; 22(9).

PMID: 33922379 PMC: 8122823. DOI: 10.3390/ijms22094400.


Targeting microbial pathogens by expression of new recombinant dermaseptin peptides in tobacco.

Khademi M, Nazarian-Firouzabadi F, Ismaili A, Shirzadian Khorramabad R Microbiologyopen. 2019; 8(11):e837.

PMID: 30912302 PMC: 6854847. DOI: 10.1002/mbo3.837.


Emerging therapeutic targets for treatment of leishmaniasis.

Sundar S, Singh B Expert Opin Ther Targets. 2018; 22(6):467-486.

PMID: 29718739 PMC: 6047532. DOI: 10.1080/14728222.2018.1472241.